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Rapid advances have been made in the field of
respiratory therapy in the past several years , resulting
in an increasing sophistication and range of application . Properly applied, these modalities have led to
significantly increased survival in patients with acute
respiratory failure and a decreased morbidity among
individuals with chronic pulmonary insufficiency . It
is the purpose of this article to put into perspective
respiratory therapy techniques and their application
in the treatment of acute respiratory failure . To this
end, we may divide respiratory therapy into five categories: I) oxygen delivery, 2) airway hygiene, 3) expansion therapy (lung inflation), 4) artificial airways,
and 5) mechanical ventilation.
While the symptoms are not specific, the onset of
acute respiratory failure is not a subtle event. Abnormal arterial blood gases are invariably present. Indeed, the entity is usually defined in terms of the
degree of alteration in the arterial blood gases. Acute
respiratory failure results from one of three general
abnormalities: I) neuromuscular dysfunction, 2) increased airway resistance, and 3) reduction of pulmonary compliance. In pure form each of these categories produces a predictable pattern of arterial
blood gas derangement. Rational management of
acute respiratory failure requires an awareness of
these alterations so that the respiratory therapy may
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be intelligently applied to stabilize or reverse the patient's pulmonary deterioration .
In the initial assessment of the patient in acute
respiratory distress, it is important to determine the
nature of the respiratory compromise. Patients with
neuromuscular dysfunction such as occurs with drug
overdose or Guillain-Barre syndrome may have normal lungs but do not have the ability to maintain an
adequate minute ventilation . The arterial blood gas
derangement consists of hypoxemia and relatively
acute hypercarbia with a normal alveolar-arterial oxygen tension gradient. Respiratory failure due to a
sudden increase in airway resistance includes entities
such as status asthmaticus , or bronchospasm with
retained secretions in patients with underlying
chronic airway disease. The arterial blood gas analysis will reveal hypoxemia with hypercarbia and a
widened alveolar-arterial oxygen tension gradient.
The functional residual capacity is elevated and , in
many patients, there is actually an increase in pulmonary compliance. The gas exchange abnormality
results from ventilation-perfusion mismatching. Patients whose respiratory failure results from an acute
loss of pulmonary compliance are those with an overwhelming parenchymal insult such as occurs with
extensive bacterial pneumonia, aspiration, or a systemic process such as pancreatitis. These disorders
may be grouped under the heading of adult respiratory distress syndrome. The physiologic alterations
are hypoxemia with hypocarbia and respiratory alkalosis because of right-to-left shunting of blood, a fall
in the pulmonary compliance, and a marked reduction in the functional residual capacity .
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Hypoxemic Hypercapneic Respiratory Failure with
Normal A-a 0 2 Gradient
The Respiratory Therapy Department of an institution becomes involved with these patients when
the decision has been made to institute mechanical
ventilation. While the initial selection of artificial airways is not in the domain of this department, usually
it is the respiratory therapists who are called upon
when these airways do not function properly. Because of the experience gained in managing airway
problems, we at the Medical College of Virginia have
developed a number of recommendations for this
aspect of respiratory care. When selecting an artificial
airway, one must make an initial decision between
"compliant" and "stiff" cuffs. We prefer to use the
large volume compliant cuff tubes because a seal is
obtained at a lower cuff pressure. Furthermore, the
intracuff pressure measured by the respiratory therapist is a more accurate assessment of pressure exerted
against the tracheal wall than pressures obtained
from stiff cuffs.
While orotracheal tubes may be rapidly inserted
during an emergency such as a drug overdose, these
tubes are associated with the highest incidence of
tracheal damage since they are difficult to stabilize
and have a tendency to move about in the trachea
when the f)atient is turned, m_oves or coughs. Nasotracheal tubes are more stable and, when a compliant cuffed tube is placed via this route, they may be
left in place for as long as two to three weeks with a
minimum of tracheal damage. The cross-sectional
diameter of the nasotracheal tube is smaller than the
orotracheal tube. The combination of longer length
and the narrow diameter may make adequate suctioning difficult. Should the management of secretions be a problem and a prolonged intubation anticipated, elective tracheostomy offers many advantages
such as the wide variety of tubes available, including
talking tracheostomy tubes, fenestrated tubes, and
cuffiess tubes; patients may be fed via the oral route;
vocal cords are not damaged ; and there is no damage
to the nasal septum. With the advent of the compliant
cuff and better management of the artificial airway,
the incidence of tracheal damage has decreased significantly. It does occur from time to time, however,
and we stress the importance of periodic monitoring
of intracuff pressure.
When the decision has been made to intubate
patients with this form of respiratory failure, and the
appropriate airway has been selected, mechanical
ventilation is usually instituted with relative ease be·
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cause of the normal physiology of the underlying
lung.

Hypoxemic Hypercapneic Respiratory Failure with
Abnormal A-a 0 2 Gradient
This disturbance is most frequently found in patients with increased airway resistance due to bronchospasm, obstructing secretions, and mucosa] swelling and edema. The immediate approach to the
hypoxemic patient is to stabilize the arterial oxygen
tension while treating the underlying defect in hopes
of avoiding intubation. The goal is to maintain the
Pao 2 in the range of 60 to 80 mm Hg which will insure
hemoglobin saturation in excess of 90%. Further increases in the arterial oxygen tension do not significantly increase oxygen delivery to the tissues. The
mode of oxygen administration is of great importance in the presence of hypercapnia. Oxygen therapy
devices are divided into high-flow or low-flow systems. A high-flow apparatus mixes oxygen and room
air prior to delivery to the patient. The gas flow
delivered by the device is sufficient to provide the
patient's total minute ventilation. Low-flow systems
do not provide enough gas flow to supply the entire
inspired atmosphere, and some part of the tidal volume will be supplied by the entrainment of room air.
Such systems may provide any concentration of oxygen from 21 % to 95%, but the fraction of inspired
oxygen (F 10 2 ) can be altered by the patient's respiratory pattern. Low-flow devices include the nasal
cannula and mask oxygen and may be used when the
tidal volume of the patient is between 300 and 700 cc,
the ventilatory rate is less than 30/ min, and there is
relatively stable ventilatory pattern with time. Because of the potential danger of excess oxygen administration, we prefer to keep the F 10 2 as low as is
consistent with adequate oxygen delivery to the tissues. The unpredictability of the tidal volume and
minute ventilation in an acutely ill patient are reasons
why we generally recommend high-flow oxygen systems; the most commonly used of these are masks
that work on the Venturi principle. The standard
inspired 0 2 fractions available are 24%, 28%, 35%,
and 40%. Humidifiers are not required with these
masks because the major portion of inspired gas is
room air. To supply a high flow of oxygen in excess of
40%, special systems can be a rranged by the Respiratory Therapy Department.
The importance of the mucociliary escalator in
maintaining airway homeostasis is often underestimated. If the mucous blanket becomes dry or
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abnormally thick, secretions . will not mobilize normally and cough will become ineffective, leading to
dramatic increases in airway resistance. The most
effective means of reestablishing the mucous blanket
is to hydrate the tracheobronchial tree. Water may be
delivered to the airway in molecular form as humidification or in particulate form as an aerosol. Simple
bubble-type humidifiers are sufficient for patients
with an intact upper airway. Should the nasopharynx
be bypassed by an artificial airway' a heater is added
to the humidifier to further increase water content. If
one wishes to deliver particulate water or medications
to aid bronchial hygiene, a nebulizing device should
be used. Ultrasonic nebulizers produce a very heavy
water mist with uniform particle size on the order of
.5µ, to 3µ,. Jet nebulizers, which operate on the Bernoulli principle, may be used for aerosolization of
both water and medications. Droplets are propelled
against baffles which eliminate the larger and heavier
particles since droplets of greater than IOµ, in size are
clinically useless as they dci not deposit in the
tracheobronchial tree. Aerosolized medications include mucolytics, bronchodilators, vasoconstrictors,
and steroids. In addition to instillation of water into
the airway, efforts have been made to change the
viscosity of the secretions by nebulizing sodium bicarbonate or acetylcysteine. Usually these agents are
no better at mobilizing dried secretions than good
hydration ; however, in circumstances where the
mucous is abnormal, such as cystic fibrosis, they may
be useful. They may also be successfully used in those
patients where active oral or intravenous hydration is
not practical or safe. Inhaled bronchodilators exert
their effect following absorption into the circulation.
Absorption from the pulmonary system is rapid and
the degree of bronchodilation obtained will be equal
to that of an intravenous dose with similar blood
levels. Vasoconstrictors may be administered by
aerosol primarily for their topical properties. Many
acute pulmonary diseases a re accompanied by an
inflammatory reaction of the respiratory mucosa
which includes profound capillary congestion and
swelling. Topical application of a vasoconstrictor
may have dramatic effei:ts in decreasing the hyperemia and increasi ng lumen size. Racemic epinephrine
is a very effective topical vasoconstrictor and a mild
systemic bronchodilator. It may be of significant benefit as adjunctive t~erapy to intravenous theophylline. Choice of nebulizing devices for any of these
medications should be made by assessing the patient's clinical status and the ability of the patient to
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generate adequate tidal volumes. We prefer that a
hand-held nebulizer be used since these devices are
inexpensive and are powered from a readily available
compressed air source. There is evidence of improved
distribution of particles when spontaneous inspiration is used with these nebulizers in contrast to
medication delivered via intermittent positive pressure breathing (I PPB). These attempts at reducing
airway resistance may be applied in conjunction with
"expansion" therapy. Incentive spirometry appears
to be superior to IPPB for preventing and treating
atelectasis.
Despite the above measures (controlled oxygen
administration, aerosolized medications, aggressive
management of secretions, and expansion therapy) a
number of patients with acute respiratory failure due
to increased airway resistance will require intubation
and mechanical ventilation. A volume-cycled ventilator is the modality of choice in acute respiratory
failure. We follow the usual guidelines of 15 cc tidal
volume/ kg of body weight, respiratory rate of 15
times per minute and F 10 2 of 40% for initial setting.
Twenty minutes to a half hour after beginning mechanical ventilation, the arterial blood gases are repeated and adjustments are made as necessary. Because the basic problem with these patients is varying
degrees o f a irway resistance in different areas of the
lung, it is advisable to use as low an inspiratory flow
rate as is consistent with the patient's ventilatory
pattern . This promotes gas delivery to poorly ventilated regions rather tha n over-expansion of well-ventilated regions. It is also important to provide for
sufficient expiratory time. If too short a period is
allowed for expiration, hyperinfl ation of the patient's
lungs beca use of gas trapping may result. A most
useful r.ecent addition to our therapeutic techniques is
intermittent mandatory ventilation (IMV). A circuit
of constant gas flow is added in parallel to the patient's ventilator allowing the patient to breathe
spontaneously at his or her own tidal volume between
pre-set breaths delivered by the volume ventilator.
This system minimizes the possibility of excessive
mechanical ventilation and allows better acid-base
control. As the patient's clinical condition improves,
the respirator rate may be gradually reduced, promoting a smoother weaning period . Complications
that may develop in patients on ventilators include
atelectasis in poorly ventilated areas, pneumot)lorax,
superinfection, or drying of secretions with mucous
plugging if the inspired atmosphere is not properly
humidified .
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Hypoxemic Hypocapneic Respiratory Failure
This blood gas pattern is found in syndromes in
which the pulmonary parenchyma has been damaged. The severity of the condition will be apparent
when there is a minimal increase in arterial oxygen
tension in response. to an F 10 2 of .4 or above. This
documents the presence of right-to-left shunting of
blood. The reduction of parenchymal compliance in
these patients makes the selection of tidal volumes
more complex than in those with obstructive problems. The pressure volume curve of the respiratory
system may be determined at the time the patient is
placed on mechanical ventilation. We are often able
to identify a point in the curve above which a slight
increase in tidal volume produces a dramatic increase
in intrathoracic pressure. This may occur at a tidal
volume as low as .7 liters. If one arbitrarily applies
the rule of 15 cc/ kg to these patients, the thoracic
capacity may be exceeded and there will be
inappropriately high intrathoracic pressure relative tp
the effective tidal volume. An appropriate minute
ventilation may · be delivered by reducing the tidal
volume and increasing the rate of ventilation. This
will reduce mean intrathoracic pressure and reduce
the incidence of barotrauma.
Most patients in this category who are gravely ill
will remain hypoxemic despite the increased F 10 2
and mechanical ventilation. These modalities po not
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reverse the primary defect of reduced Functional Residual Capacity. This problem may be partially corrected by increasing the distending pressure within
the thorax. This is done by applying positive end
expiratory pressure (PEEP). Com'plications include a
reduction in cardiac output and pneumothorax. It
should be noted, however, that the occurrence of
pneumothorax is related to the level of me(ln intrathoracic pressure during mechanical ventilation and
not to the presence or absence of PEEP.
In . summary, respiratory therapy should be
thought of as a series of specific steps designed to
treat the anatomic and physiologic alterations that
occur with the various forms of respiratory failure,
The scientific basis of the field is rapidly advancing as
more is learned about the mechanisms of pulmonary
disease. Respiratory therapy should no longer be
equated solely with IPPB but should be regarded as a
field encompassing a number of effective treatment
modalities.
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